BIOMAT Database Logo BIOMAT Database Logo

Detection of breast tumor antigen-sensitive circulating T-lymphocytes by antigen-stimulated active rosette formation. 1979

W G Ramey, and G A Hashim, and W B Burrows, and A J Swistel, and A Munther, and H F Fitzpatrick

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D012397 Rosette Formation The in vitro formation of clusters consisting of a cell (usually a lymphocyte) surrounded by antigenic cells or antigen-bearing particles (usually erythrocytes, which may or may not be coated with antibody or antibody and complement). The rosette-forming cell may be an antibody-forming cell, a memory cell, a T-cell, a cell bearing surface cytophilic antibodies, or a monocyte possessing Fc receptors. Rosette formation can be used to identify specific populations of these cells. Immunocytoadherence,Formation, Rosette,Formations, Rosette,Immunocytoadherences,Rosette Formations
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

W G Ramey, and G A Hashim, and W B Burrows, and A J Swistel, and A Munther, and H F Fitzpatrick
Antigen-stimulated rosette formation by T lymphocytes in experimental allergic encephalomyelitis.
February 1977, Neurochemical research,
W G Ramey, and G A Hashim, and W B Burrows, and A J Swistel, and A Munther, and H F Fitzpatrick
Active T rosette formation of human T lymphocytes after stimulation with lectins.
September 1984, Journal of UOEH,
W G Ramey, and G A Hashim, and W B Burrows, and A J Swistel, and A Munther, and H F Fitzpatrick
Mechanisms of E-rosette formation by mitogen-stimulated canine lymphocytes.
February 1980, Immunology,
W G Ramey, and G A Hashim, and W B Burrows, and A J Swistel, and A Munther, and H F Fitzpatrick
Inhibition of the active E-rosette-forming T lymphocytes by a mesenchyme associated antigen.
February 1980, Biomedicine / [publiee pour l'A.A.I.C.I.G.],
W G Ramey, and G A Hashim, and W B Burrows, and A J Swistel, and A Munther, and H F Fitzpatrick
Rosette formation by human T and B lymphocytes.
January 1973, European journal of immunology,
W G Ramey, and G A Hashim, and W B Burrows, and A J Swistel, and A Munther, and H F Fitzpatrick
Rosette formation by circulating lymphocytes from rheumatoid and nonrheumatoid subjects.
May 1972, Annals of the rheumatic diseases,
W G Ramey, and G A Hashim, and W B Burrows, and A J Swistel, and A Munther, and H F Fitzpatrick
[Detection of sensitized lymphocytes in myocardial infarct by the active rosette formation inhibition reaction].
January 1985, Laboratornoe delo,
W G Ramey, and G A Hashim, and W B Burrows, and A J Swistel, and A Munther, and H F Fitzpatrick
Augmentation of E-rosette formation by lymphocytes of cancer patients stimulated in vitro with tumor extracts.
October 1980, The Australian journal of experimental biology and medical science,
W G Ramey, and G A Hashim, and W B Burrows, and A J Swistel, and A Munther, and H F Fitzpatrick
Differentiating feline T and B lymphocytes by rosette formation.
September 1975, Journal of immunology (Baltimore, Md. : 1950),
W G Ramey, and G A Hashim, and W B Burrows, and A J Swistel, and A Munther, and H F Fitzpatrick
Properties of bispecific rosette-forming cells. II. --Rosette formation by "educated" T-lymphocytes.
April 1975, Annales d'immunologie,
Copied contents to your clipboard!